Search alternatives:
near resistance » wear resistance (Expand Search), shear resistance (Expand Search), new resistance (Expand Search)
heat resistance » host resistance (Expand Search), plant resistance (Expand Search), high resistance (Expand Search)
decrease tumor » increased tumor (Expand Search)
Showing 21 - 40 results of 2,187 for search '(( decrease tumor resistance ) OR ( decrease ((near resistance) OR (heat resistance)) ))', query time: 0.54s Refine Results
  1. 21
    Drug combinations with trametinib decrease the colony-forming ability of GIST cell lines.

    Drug combinations with trametinib decrease the colony-forming ability of GIST cell lines. by Anu Gupta (467592)

    Published 2021
    Save to List
    Saved in:
  2. 22
    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  3. 23
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  4. 24
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  5. 25
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  6. 26
    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  7. 27
    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  8. 28
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  9. 29
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    “…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
    Save to List
    Saved in:
  10. 30
    Novel chromobox 2 inhibitory peptide decreases tumor progression

    Novel chromobox 2 inhibitory peptide decreases tumor progression by Lindsay W. Brubaker (15099942)

    Published 2023
    Save to List
    Saved in:
  11. 31
    Hypoxia Resistance of Sterile Mutants.

    Hypoxia Resistance of Sterile Mutants. by Cassidy Hemphill (12667290)

    Published 2022
    “…Data show that germline ablated animals (<i>glp-1(ts)</i> and <i>glp-4(ts)</i>), masculinized <i>fem-3(q20)</i> mutants (<i>fem-3(masculinized)</i>) and <i>gld-1(tumor)</i> mutants are highly resistant to hypoxic injury, whereas the feminized <i>fem-3(e2006)</i> mutant (<i>fem-3(feminized)</i>) displays close to wild type hypoxia sensitivity. …”
    Save to List
    Saved in:
  12. 32
    Supplementary Figure 3 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression

    Supplementary Figure 3 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression by Thomas J. Rogers (8041841)

    Published 2023
    Save to List
    Saved in:
  13. 33
    Supplementary Figure 2 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression

    Supplementary Figure 2 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression by Thomas J. Rogers (8041841)

    Published 2023
    Save to List
    Saved in:
  14. 34
    Supplementary Figure 1 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression

    Supplementary Figure 1 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression by Thomas J. Rogers (8041841)

    Published 2023
    Save to List
    Saved in:
  15. 35
    Measuring instrument (a) Armored thermal resistance for high voltage and waterproof ground (b) Thermal resistance of measuring the inlet and outlet water temperature (c) Turbine flowmeter of testing GHE flow.

    Measuring instrument (a) Armored thermal resistance for high voltage and waterproof ground (b) Thermal resistance of measuring the inlet and outlet water temperature (c) Turbine fl... by Rui Zhang (13940)

    Published 2025
    Save to List
    Saved in:
  16. 36
    Cabozantinib treatment decreases microvessel density and increases hypoxic stress in SCNPC PDX models.

    Cabozantinib treatment decreases microvessel density and increases hypoxic stress in SCNPC PDX models. by Mark P. Labrecque (10011469)

    Published 2021
    Save to List
    Saved in:
  17. 37
    Supplementary Figures from Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors

    Supplementary Figures from Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors by Damir Varešlija (7954046)

    Published 2023
    “…Ligand independent ER drives growth of AI resistant cells. Figure S2. Confirmation of transient knockdown using siRNA. …”
    Save to List
    Saved in:
  18. 38
    Overexpression of TMEM182 renders human OSCC cells resistance to miR-450a-decreased cell adhesion.

    Overexpression of TMEM182 renders human OSCC cells resistance to miR-450a-decreased cell adhesion. by En-Wei Hsing (154990)

    Published 2019
    Save to List
    Saved in:
  19. 39
    The SsdC mutant is defective in both germination and heat-resistance.

    The SsdC mutant is defective in both germination and heat-resistance. by Johana Luhur (9767765)

    Published 2020
    Save to List
    Saved in:
  20. 40
    Figure S6. Treatment with a CCR4 antagonist decreases CCR4+ Tregs and increases T cell/Treg ratios in murine glioma. from CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells

    Figure S6. Treatment with a CCR4 antagonist decreases CCR4+ Tregs and increases T cell/Treg ratios in murine glioma. from CCL2 Produced by the Glioma Microenvironment Is Essential... by Alan L. Chang (14250716)

    Published 2023
    Save to List
    Saved in:

Search Tools: